Head of R&D and Medical Project Management at Boehringer Ingelheim España. He is a health professional with a medical and clinical background and extensive experience in the pharmaceutical sector managing a portfolio of research, development and innovation projects at all stages of maturity. He has taught at various universities and business schools. His areas of expertise and interest include health and medicine, science and innovation management, drug and device development, project and portfolio management, entrepreneurship, scouting, outsourcing, training and education.
After twenty years of experience, Jaume Amat has been involved as a founder in more than 10 biomedical start-ups.
He is a Telecommunications Engineers with business formation from IESE (PDD), Motivation and Leadership from Auckland Business School and Social Leadership from ESADE.
Professional with Business Administration and Management degree at the University of Barcelona and MBA at ESADE Business School. Specialized in finance in both studies.
Large professional trajectory as financial external auditor as well as internal auditor working in a wide range of projects in multinational companies in an international environment.
International experience working as Internal Auditor based in Amsterdam.
Extensive experience on financial controlling and project management in my current position at Laboratorios Entema.
Graduate in Biochemistry and Master in Science, Technology and Society Studies from the University of Salamanca, Jorge Barrero has been Director General of the Cabinet of the Ministry of Science and Innovation, Cristina Garmendia, exercising functions in the general coordination of the political action of the Ministry, and supervising the public agenda, parliamentary activity and relations with the media. He was deputy to the presidency and general secretary of ASEBIO, the Spanish Association of biotechnology enterprises, and he previously developed his career in the field of strategic consulting in the biotechnology sector and in the public R&D system. He regularly collaborates with the media and has taught at various universities and business schools.
Mr. Friedmann spent 28 years in the healthcare industry, 14 of them with GE Healthcare in a number of Sales and Marketing leadership positions in Europe. Mr. Friedmann has a strong strategic and operational commercial foundation. He co-founded 37celsius Capital Partners, he is serving to grow a telehealth company, Telemedcare LLC, in FL and Spain, and he served in several European programmes as well as in a number of healthcare enterprises associations.
He received a Master degree in Marketing (ESIC), Master degree in Pharmaceutical Marketing and Management (EADA) and a Bachelor’s degree in Chemical engineering (UAB). He is also the Co-Author of a Pharmaceutical Market access edition “Todo lo que debe saber sobre Marketing Farmacéutico”.
Professor of Medicine at the University of Barcelona, director of the Paediatric Arrhythmia Unit at Hospital Sant Joan de Déu, a senior consultant at Hospital Clinic Barcelona and president of the Brugada Foundation. He was chief of Cardiology and medical director of Hospital Clinic Barcelona from 2006-2014. Also, he was president of the European Heart Rhythm Association (EHRA) and vice president of the Spanish Society of Cardiology. His contribution to the medical community is extensive, including more than 400 publications on cardiac arrhythmias and 300 international lectures.
With and MBA from Boston University, Elena is one of EMEA’s most experienced tech transfer executives, having completed hundreds of license and research deals in different industries.
Prior to co-founding Inveniam, Elena served as VP of Technology Transfer at world leader Marqera LLC, as VP for R&D collaborations at Hebrew University in Jerusalem, was Manager at Razei Bar (nutraceuticals), and Marketing Manager at Orgenics (diagnostics).
Xavier Carbonell has a Degree in Medicine and Surgery 1994 with a postgraduate degree in sports medicine. EMBA at ESADE 2003-2004.
He served as a Medical and Marketing Director at Novartis Oncology 2000-2004, at Amgen Spain’s as Oncology Director 2004-2007.
He’s currently CEO of Palex Group since 2007.
He’s member of the Palex Group Board, Abex Robotic Excellence Board, FENIN Executive Committee Member (Spanish Federation of Health Technology Companies) since 2017; and the Spanish Chamber of Commerce, Commission of Industry and Innovation.
I work to promote technology clustering and technology-based economic development in Catalonia. I specialize in technology transfer, technology entrepreneurship and research infrastructure management. I have been director of two science and technology parks and director of entrepreneurship at the Generalitat de Catalunya. I am currently in charge of the Research and Technology Transfer Office at the University of Girona.
PhD in Bioengineering from the UPC, Albert is an experienced professional in Industrial R&D, Bioengineering R&D and industry-academia partnerships.
He is currently Associate Professor at UB’s Faculty of Medicine and completed his post-doc at Hospital Clinic.
He is also Head of R&D unit for Energy and Systems at an infrastructure company.
Dr. Donoso-Bach has been specially focused in the development and implementation of IT in diagnostic radiology. He served as President of the Spanish Society for Diagnostic Radiology (SERAM), President of the Spanish Foundation of Radiology and President of the European Society of Radiology (ESR). Recently he was nominated President of the International Society of Strategic Studies in Radiology (IS3R) and President of the International Society of Radiology (ISR). He has received numerous honours for his contributions to the discipline, including the Gold Medal of the SERAM, the Gold Medal of the Interamerican College of Radiology (CIR) and the Gold Medal of the ESR as well as numerous honorary memberships in radiological societies around the globe.
Director of Digital Health and Technology at Ferrer, where she leads the collective effort to reimagine the company by leveraging “digital” on behalf of patients, doctors, payers, partners and employees to have asustainable impact on healthcare. She transitioned to digital health in 2018 after 23 years in clinical development at pharma companies and CROs, as well as in the public sector (Catalan Ministry of Health). She holds a PhD in Biochemistry and Molecular Biology from the University of Barcelona, New England Medical Center (Tufts University, Boston), and an Executive Management Degree from ESADE.
PhD in Pharmacy from the University of Barcelona (UB), PDD from IESE and Leadership Program from ESADE.
Operations Director at Uriach since 2013, Farrés is member of the company’s Management Committee.
Previously, he developed a professional career in companies like Synthon and Sanofi-Aventis. He is also a mentor at IQS Next Tech.
With a proven track record of product and go to market innovation to deliver strong businessgrowth rates. He is passionate about building and leading teams to their best results andcrafting win-win relationships with channel partners, employees and customers.
Ellen Goldberg is Founder and President of CHORD Consulting, which provides product and marketing strategy consulting to innovative companies driving step-change improvements in healthcare. Ellen has focused her career on developing and commercializing ground-breaking products in life-altering diseases. She led marketing at Genomic Health, Inc., where she launched the Oncotype DX® Breast Cancer Assay which empowers >80,000 women annually to make better decisions about chemotherapy. As VP of Marketing at Crescendo Bioscience, she launched Vectra DA® to help improve outcomes in rheumatoid arthritis. Ellen began her career at Booz Allen & Hamilton and developed new products at ALZA Corp. Ellen has an MS in Chemistry and an MBA from Stanford University and a BS from Yale University.
MBA, experienced CEO (now at Newmanbrain) and board director in the biosanitary field, specialized in mergers and acquisitions, as in the incorporation, venture capital funding and launching of spinoffs. He has closed joint development and marketing agreements on four continents and is considered an expert in open innovation. He advises corporates and governmental bodies on novel technologies valuation, and have been coordinating committees of experts, mainly in biotechnology and biomedical technologies, for more than two decades. His last works are related to fields such as CAR-T cells therapies, diagnostics devices, nanosensors national industry development (abroad, on a World Bank-funded mission), global strategic alliances to develop AI-based systems, nanotech for drug delivery; he is currently a member at several director boards, and investments committees.
Biomedical venture builder and entrepreneur with over 20 years of senior management experience in the biopharmaceutical sector, coupled with close to 5 years of investment banking experience. Broad subject matter expertise ranging from innovation management to commercial operations, and general management at an international level. He holds a Bachelor of Economics from Tufts University, MBA from IESE, and an Advanced Management Program from Harvard Business School.
Serial entrepreneur, technology executive and advisor to numerous start-ups in the US and Europe. As a 15-year veteran of the tech industry (SaaS, cloud and digital marketing), he has been working with the leading tech providers in this arena. Most recently, he co-founded and served as CEO at Perfect Dashboard. He is an ambassador to Berkeley SkyDeck, the official accelerator of UC Berkeley in California, and teaches the entrepreneurship and start-up course at AGH University of Science and Technology.
Chief Financial Officer of Blueberry Diagnostics and expert evaluator of EIC accelerator for the SME instrument since 2019, Roger has worked for 13 years at Conduent BPO services as Internal Control Manager for multinational clients such as General Motors, Michelin, Xerox or Atos.
For the last 5 years he has been a business angel, member of ESADEBAN with more than 20 companies in his portfolio, investing in different sectors like ICT or cleantech but especially in the healthcare sector and he is currently working in a promising healthcare company.
Health and business entrepreneur with over 15 years of management experience in the health sector, coupled with close to 8 years of helicopter and tourism experience. Broad subject matter expertise ranging from innovation management to commercial operations, and general management at an international level. He holds a Bachelor of Business, MBHealth from EADA, and Digital Product Managament. Nuclio Digital School. Barcelona.
Professional experience mainly developed in the Pharmaceutical and Consumer Health Care sector in C-suite executive positions with background in Sales, Marketing, Business Development at local and international level (Belgium, Switzerland, Portugal, Spain, The Netherlands, Hong Kong…). Worked for Novartis, Almirall, UCB or Vemedia among others. Experienced as a growth consultant for start-up companies in Chicago, USA. He supports professionals, start-ups and pharmaceutical companies on the value creation process.
Bachelor’s Degree in Pharmacy and finalizing a B. A in History, postgraduate in Pharmaceutical Marketing. Additionally, obtained an MBA degree from Kellogg School of Management, Northwestern University in USA.
Graduated in Management and Business Science from the University Pompeu Fabra where she was enrolled in a exchange program at University of British Columbia (Canada).
Specialized in Audit and Financial management from the Barcelona School of Management and with almost 4 years of experience working as an audior, she dealt with clients from different industries including the farmaceutical sector. She is currently working as a Senior Associate at M&A Transaction Advicory Services at PwC, one of the top leaders in the sector, focused on financial due diligence. She passed the CFA Level I on February 2022.
A Project Leader with over 20 years international experience in the Biopharma industry covering R&D, product launches and business models. Have successful led more than 150 launches worldwide. In-depth experience in managing complex multi-partner projects. Able to manage cross-functional teams and execute project plans according to timeline and budget. Experience in portfolio management and evaluation of strategic business options. Have supported business development transactions and implementation of deals.
Experience of working across different functional areas and building business relationships with external partners and suppliers (Pfizer, GSK, Menarini, Allergan, Forest, Kyorin, Daewoong…). Able to influence key stakeholders based on clear analysis and evaluation of strategic options.
Adjunct Professor, Corporate Innovation at IE University. Adjunct professor, Strategic Management at EAE Business School
Ph.D. in Organic Chemistry UB, Program for Management Development-PMD Executive Education ESADE, Digital Business Executive Program-DIBEX ISDI
Doctor of medicine and surgery. Urology specialist. Subspecialty: lithiasis and endourology. Clinical Head of the Urology Department of the Puigvert Foundation.
Master in Design and Statistics in Health Sciences. Integrative Medicine.
After 15 years of experience in capital markets and corporate finance in Spain and Portugal, Tomas joined the Madrid Bar Association in 2005, assisting corporations in financial matters. Since then, he has participated at the C level in family owned companies and as a board member in several projects, assuming the role of CFO in transition. His broad experience is complemented by a solid and diverse academic background.
Tomas has a degree in Biology from the Universidad de Barcelona, a degree in Law from UNED, an MBA from IESE Business School, an executive degree in International Finance from Georgetown University and a degree in Digital Business from ISDI.
Seasonal entrepreneur with a broad international experience in healthcare industry, instrumental in cross cultural business agreements. Over 20 years’ in international marketing, sales, and portfolio management positions. Board member of start-up biotech companies.
Master in Business Administration, CEMS degree, ESADE Business School, Barcelona, Spain; Commercial Engineer & Business Administration, Université Catholique de Louvain, Belgium
Founder and partner at Laboratorios Asderco (Spain), Board Member of Accure Therapeutics (Spain), Founder and partner at Pharmaphenix (Spain), Business Development Europe at Reaction Biology, (USA), Director Strategic Marketing and Business Development, Laboratorios Rubió (Spain), International Marketing Manager / Area Manager, Almirall (Spain).
PhD in Organic Chemistry. MBA by ESADE and a PADE by IESE. He is linked to more than 10 Biotech companies in Spain performing as a Consultant Assessor and/or Business Angel.
Dr. Parente started his career in Laboratorios Vita S.A. Since 1989, he has been co-founder of several companies, – including Lipotec SA, BCN Peptides SA, Diverdrugs SL, Lipofoods SA, BCN Corp SL and Primaderm SA – where he acted as Manager, CEO or Executive President . In 2000, he founded GP Pharm where he is current President.
Besides these activities, Dr. Parente is at the Business Council of the Centre for Genomic Regulation (CRG Barcelona) and was Vice-president of ASEBIO (Spanish Association of Biotech companies), Co-founder, President and Vice-president of CataloniaBio (Catalan Association of Biotech companies ) and Vice-president of Biocat (Foundation to Promote Life Science Sector in Catalonia).
Frederic Pascual holds a M.B.A by I.A.E- Paris Sorbonne Business School, a Master’s Degree in Engineering by Polytech’ Montpellier in microelectronics & robotics and a BTEC Higher National Diploma in physical measurements.
He has 25 years’ international experience in design, construction, C&Q, validation and compliance of cleanroom for pharmaceutical plants across 18 countries.
After 12-year experience as founder and CEO of a small & medium enterprises manufacturing leisure vehicles, he has joined Valtria Engineering and Devecan as associated founder.
He is president of A3P Spain.
Currently an ANQUOR CORPORATE FINANCE Partner, Piqueras has been developing his activity in the chemical-pharmaceutical sector for more than 35 years, where he has held different responsibilities in companies in the sector such as Boehringer Mannheim, Hoffmann La Roche, Kern Pharma and its parent company the Indukern Group.
During the last two years he has also been an advisor to the corporate finance firm EUROHOLD, in the field of health sciences. Outstanding among his most relevant positions and projects is that of Technical Director and later Managing Director at the pharmaceutical company Kern Pharma, one of the leaders in the sector, as well as director of M&A for the entire Indukern Group, promoting both organic and inorganic growth.
Josep Maria has a degree in Pharmacy, holds an MBA and combines his professional activity with the presidency of the Pere Suñé de L’Hospitalet Atletisme Foundation and the L’Hospitalet Atletisme club.
He has 20 years of experience in human resources (HR) in a wide variety of business sectors and cycles: pharmaceutics (Sanofi), consultancy (Buck Consultants), online banking (Uno-e and BBVA group) and telecommunications (Broadnet). He held national and international executive positions at all of these companies and was in close contact with start-ups and innovation ecosystems. He has a degree in Economics from the University of Leon and an MBA from IE Business School. He collaborates with several business schools, business associations (AEDIPE, Barcelona Global, AED and CírculoEcuestre) and media outlets, and is co-author of the book Control 2.0.
With a degree in Biological Sciences from the Autonomous University of Madrid, a Master in Biotech business management and experts in international R & D & I programs, Irene Sánchez has been linked to the public sector as a senior manager of European framework programs at the Ministry of Science and Innovation, Ministry of Economy and Competitiveness, Carlos III Health Institute and National Center for Biotechnology-CSIC.
She is currently responsible for Innovation in the Scientific Foundation of the Spanish Association Against Cancer and regularly participates as a teacher in Universities and business schools teaching topics related to the management of innovation programs in the area of biomedicine.
Regional Field Market Acces Head at Novo Nordisk in Spain, Biology degree from the University of Barcelona (1994). Professional with over 25 years of experience in the pharmaceutical industry, focusing on sales and market access.
Mostly patient-centered, with a focus on recognising and meeting needs with the goal of improving quality of life, or in other words, improving the health.
Currently collaborating with the Market Access program at Eada Business School in Barcelona. Providing the knowledge and skills necessary to meet the pharmaceutical industry’s new challenges.
As a Senior Marketing Manager, Ricardo brings more than 30 years’ experience in introducing innovative medical & industrial products into new and existing markets, worldwide. Consistently succeed in promoting new products into value propositions in small & large companies. Ricardo has experience in a long list of Medical products and Cleantech and Agrotech technologies.
Schleifer is MSc in Bio-Medical Engineering from the Tel Aviv University and BSc in Mechanical Engineering from the Technion (both cum-laude).
Mark is the Founder and managing director of BiomedRed, a Spanish-based scientific communications and consultancy company. He has experience in preparing, translating and editing biomedical texts for publication, preparing grant proposals, administrative management ofsuccessful EU consortia, and preparing multimedia material for the diffusion and dissemination of scientific activities. He holds a PhD from the University of Cambridge
Executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and medical affairs.
Chief Medical Officer of ASC Therapeutics, former CMO for Symvivo, Myriad Genetics and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie.
Senior medical leader experienced in matrixed, line management and consulting for biotechs, midsize and large pharma companies. Extensive expertise in gene therapy, immuno-oncology , immuno-therapy, genomics and protein/cell diagnostics, predominantly focused on oncology, hematology and autoimmunity, including personalized medicine, molecular and cellular biomarkers.
Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain.
Dr. Jordi Serrano Pons is a medical doctor and founder & CEO of UniversalDoctor: The Digital Global Health Company. UniversalDoctor won the United Nations World Summit Award for Global Champion of the mHealth category in 2015 and has implemented Digital Global Health projects in more than 20 countries.
Jordi is a widely recognized leader in the digital health and innovation space, consulting for the World Health Organization (WHO) and other key health institutions. He was recently named one of the Top 50 Healthcare IT Leaders in Europe as part of the Future50 classification, supported by IBM Watson Health, a new initiative by HIMSSEurope.
Jordi is also the co-founder of Zero Mothers Die, a global partnership initiative reducing maternal mortality through mobile technology solutions.
Juan Subarroca is a professional with more than 20 years of experience in companies with servicies focused on Health Sciences. He is a Thermomechanical Engineer.
Founding partner of the Valtria Group, currently the LATAM Director of Valtria.
He has been president of ISPE Argentina and currently General Secretary of this organization.
Dr. Tarragó has a PhD in Molecular Biology from the University of Barcelona. She has solid expertise in drug discovery, gained during 15 years spent conducting several research lines on proteases and protease inhibitors at the Spanish National Research Council (CSIC) and IRB Barcelona. She has experience in managing internationally-funded research projects, as well as directing joint undertakings with biotech companies. She has published over 40 papers and two books, and she holds four patents. In addition to her scientific qualifications, she holds an Executive MBA (ESADE) and has participated in entrepreneurship programmes, including “Ignite” at Cambridge Judge Business School and “BioEmprendedor XXI” (Barcelona).
Co-Founder and former CEO at Iproteos. She is Board Member at Accure Therapeutics. She is currently a Business Advisor at Caixa Impulse, as well as a mentor at EIT Health. She has also been nominated as one of the 10 best European female entrepreneurs in the field of biotechnology in 2019 by Labiomed. She is currently co-founder and CEO at Exheus.
We use our own and third party cookies to improve your experience and to optimize the operation on the web. If you continue browsing we consider that you accept our cookies policy. More information
La configuració de les galetes d'aquesta web està definida com a "permet galetes" per poder oferir-te una millor experiència de navegació. Si continues utilitzant aquest lloc web sense canviar la configuració de galetes o bé cliques a "Acceptar" entendrem que hi estàs d'acord.